2017-03-20 12:55:17 UTC

Gastroenterologists Trust UpToDate®

March 20, 2017

AGA partner UpToDate® is the premier evidence-based clinical decision support resource, trusted by health-care practitioners to help them make the right decisions at the point-of-care.

With access to more than 10,500 topics spanning 24 specialties, you can find the answers you need quickly and easily with UpToDate®. Content is written and continuously updated by expert leaders in their respective medical disciplines, so you can be confident that the information is reliable, evidence-based, and reflects current standards of care.

View UpToDate gastroenterology and hepatology sample topics.

UpToDate supports your MOC efforts.
Health-care professionals can use the time they spend with UpToDate answering questions quickly to fulfill ABIM MOC and other MOC Part II CME activity requirements.

Sign up for a free trial.
As an AGA member, you are also entitled to a 14-day, no obligation free trial to UpToDate. Simply log in as an AGA member to take advantage of this special offer.

Join your colleagues and try UpToDate risk-free.*
Subscribe to UpToDate today and see what a difference it can make in your practice.

*If you aren’t completely satisfied, simply cancel your annual (or longer) subscription within 60 days and request a full refund (issued in U.S. dollars).

More on Continuing Education

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Comprehensive Update of Biosimilar Therapies: Your Questions Answered

Dec. 11, 2017

Gain a better understanding of the evidence currently available on biosimilars for IBD and how to educate/discuss biosimilars with patients.